Subinhibitory concentrations of trimethoprim and sulfamethoxazole prevent biofilm formation by Acinetobacter baumannii through inhibition of Csu pilus expression [PDF]
, 2017 Acinetobacter baumannii is emerging as a multidrug-resistant nosocomial pathogen of increasing threat to human health worldwide. Pili are important bacterial virulence factors, playing a role in attachment to host cells and biofilm formation.
Feldman, Mario F +2 more
core +4 more sources
Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. [PDF]
PLoS ONE, 2013 Acinetobacter baumannii is an emergent and global nosocomial pathogen. In addition to A. baumannii, other Acinetobacter species, especially those in the Acinetobacter calcoaceticus-baumannii (Acb) complex, have also been associated with serious human ...
Jason W Sahl +6 more
doaj +7 more sources
Brazilian Journal of Infectious Diseases, 2022 Introdução e objetivos: O Acinetobacter baumannii é patógeno associado a IRAS em unidades de terapia neonatais. Outras espécies de Acinetobacter tem sido relacionadas a infecções nosocomiais.
Marcilene Maria de Souza Viana +2 more
doaj +1 more source
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex
Clinical Infectious Diseases, 2023 Acinetobacter baumannii-calcoaceticus complex is the most commonly identified species in the genus Acinetobacter and it accounts for a large percentage of nosocomial infections, including bacteremia, pneumonia, and infections of the skin and urinary ...
M. Castanheira, R. Mendes, A. Gales
semanticscholar +1 more source
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
Antibiotics, 2023 Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the treatment of infections caused by multidrug-resistant A.
K. Novović, B. Jovčić
semanticscholar +1 more source
A global view on carbapenem-resistant Acinetobacter baumannii
mBio, 2023 To give an update on the molecular epidemiology and global distribution of carbapenemase encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated from 114 study centers in 47 countries in five world regions, Africa, Asia ...
C. Müller +7 more
semanticscholar +1 more source
Virulence, 2023 Acinetobacter baumannii is a common cause of healthcare-associated infections and hospital outbreaks, particularly in intensive care units. Much of the success of A.
M. Lucidi +6 more
semanticscholar +1 more source
Acinetobacter baumannii in the critically ill: complex infections get complicated
Frontiers in Microbiology, 2023 Acinetobacter baumannii is increasingly associated with various epidemics, representing a serious concern due to the broad level of antimicrobial resistance and clinical manifestations. During the last decades, A.
Ilaria Cavallo +8 more
semanticscholar +1 more source
Acinetobacter Baumannii Phages: Past, Present and Future
Viruses, 2023 Acinetobacter baumannii (A. baumannii) is one of the most common clinical pathogens and a typical multi-drug resistant (MDR) bacterium. With the increase of drug-resistant A.
Qihang Tu +9 more
semanticscholar +1 more source
Investigating bacteriophages targeting the opportunistic pathogen Acinetobacter baumannii [PDF]
, 2020 The multi-drug resistance of the opportunistic pathogen Acinetobacter baumannii is of growing concern, with many clinical isolates proving to be resistant to last resort as well as front line antibiotic treatments.
Christie, Gabrielle S. +10 more
core +1 more source